[Antenatal prevention of early neonatal bacterial infection (September 2001)].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000994:Antitrichomonal Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D004359:Drug Therapy, Combination; D005260:Female; D005322:Premature Rupture of Fetal Membranes / Q000175:diagnosis / Q000382:microbiology; D005602:France; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D007769:Lactams; D018942:Macrolides; D009313:National Health Programs; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D002575:Uterine Cervicitis / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D014627:Vaginitis / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology
D000900:Anti-Bacterial Agents; D000994:Antitrichomonal Agents; D007769:Lactams; D018942:Macrolides